Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Oct;19(10):1581-91.
doi: 10.1007/s00520-010-0986-7. Epub 2010 Sep 12.

Factors predicting clinically significant fatigue in women following treatment for primary breast cancer

Affiliations

Factors predicting clinically significant fatigue in women following treatment for primary breast cancer

Lynn H Gerber et al. Support Care Cancer. 2011 Oct.

Abstract

Cancer-related fatigue is common, complex, and distressing. It affects 70-100% of patients receiving chemotherapy and a significant number who have completed their treatments. We assessed a number of variables in women newly diagnosed with primary breast cancer (BrCa) to determine whether biological and/or functional measures are likely to be associated with the development of clinically significant fatigue (CSF). Two hundred twenty-three women participated in a study designed to document the impact of the diagnosis and treatment of primary breast cancer on function. Forty-four had complete data on all variables of interest at the time of confirmed diagnosis but prior to treatment (baseline) and ≥ 9 months post-diagnosis. Objective measures and descriptive variables included history, physical examination, limb volume, hemoglobin, white blood cell count, and glucose. Patient-reported outcomes included a verbal numerical rating of fatigue (0-10, a score of ≥ 4 was CSF), five subscales of the SF-36, Physical Activity Survey, and Sleep Questionnaire. At baseline, the entire cohort (n = 223) and the subset (n = 44) were not significantly different for demographic, biological, and self-reported data, except for younger age (p = 0.03) and ER+ (p = 0.01). Forty-five percent had body mass index (BMI) ≥ 25, 52% were post-menopause, and 52% received modified radical mastectomy, 39% lumpectomy, 52% chemotherapy, 68% radiation, and 86% hormonal therapy. Number of patients with CSF increased from 1 at baseline to 11 at ≥ 9 months of follow-up. CSF at ≥ 9 months significantly correlated with BMI ≥ 25, abnormal white blood cell count, and increase in limb volume and inversely correlated with vigorous activity and physical function (p < 0.05). Fatigue increases significantly following the treatment of BrCa. Predictors of CSF include high BMI and WBC count, increase in limb volume, and low level of physical activity. These are remediable.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Surveillance plan

Similar articles

Cited by

References

    1. Cella D, Davis K, Breitbart W, et al. Cancer related fatigue: prevalence of proposed diagnostic criteria in a United States sampling of cancer survivors. J Clin Oncol. 2001;19:3385–3391. - PubMed
    1. Hofman M, Ryan JL, Figueora-Moseley CD, et al. Cancer related fatigue: scale of the problem. Oncologist. 2007;12(Suppl 1):4–10. doi: 10.1634/theoncologist.12-S1-4. - DOI - PubMed
    1. Bower JE. Prevalence and causes of fatigue in long-term breast carcinoma survivors: a longitudinal investigation. Cancer. 2005;106:751–758. doi: 10.1002/cncr.21671. - DOI - PubMed
    1. Curt GA. Impact of fatigue on quality of life in oncology patients. Semin Hematol. 2000;37(4 suppl 6):14–17. doi: 10.1016/S0037-1963(00)90063-5. - DOI - PubMed
    1. Nieboer P, Buijsc RS, et al. Fatigue and relating factors in high risk breast cancer patients treated with adjuvant standard-or high dose chemo therapy. J Clin Oncol. 2005;23:8296–8304. doi: 10.1200/JCO.2005.10.167. - DOI - PubMed

Publication types

Substances